Weight-loss jabs such as Wegovy could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire.
More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to westernised diets and more sedentary lifestyles.
The World Health Organization designated semaglutide – sold to treat obesity under the brand name Wegovy, and diabetes under the brand name Ozempic – as an essential medicine in September last year.
But global health leaders warned at the time that high prices were limiting access.
New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about £2.35) for a monthly dose in its injectable form.
Now if we only stopped thinking that willpower is some magical fairy dust we were all granted when we turned 18 and not using it “correctly” indicates moral failure.
For real, this just boggles my mind. All this neuroscience, psychology, biology and so many still somehow believe in some vague magical essence that is totally independent of any biological or environmental factors.